Literature DB >> 17255312

Protection against endotoxic shock as a consequence of reduced nitrosative stress in MLCK210-null mice.

Hantamalala Ralay Ranaivo1, Nunzia Carusio, Rosemary Wangensteen, Patrick Ohlmann, Cecile Loichot, Angela Tesse, Karel Chalupsky, Irina Lobysheva, Jacques Haiech, D Martin Watterson, Ramaroson Andriantsitohaina.   

Abstract

This study investigated the consequences of deletion of the long isoform of myosin light chain kinase (MLCK210) on the cardiovascular changes induced by the bacterial endotoxin lipopolysaccharide (LPS) and cecal ligation puncture using MLCK210-/- mice. Here, we provide evidence that deletion of MLCK210 enhanced survival after intraperitoneal injection of LPS or cecal ligation puncture. LPS-induced vascular hyporeactivity to vasoconstrictor agents was completely prevented in aorta from MLCK210-/- mice. This was associated with a decreased up-regulation of nuclear facor-kappaB expression and activity, inducible nitric-oxide synthase, and level of oxidative stress in the vascular media. Furthermore, LPS-induced increase of nitric oxide production in the circulation and tissues (including heart, liver, and lung) that was correlated with an increased expression of inducible nitric-oxide synthase was also reduced in MLCK210-/- mice. These data demonstrate a role for MLCK210 in endotoxin shock injury associated with oxidative and nitrosative stresses and vascular hyporeactivity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255312      PMCID: PMC1851870          DOI: 10.2353/ajpath.2007.060219

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Characterization of tumor necrosis factor-deficient mice.

Authors:  M W Marino; A Dunn; D Grail; M Inglese; Y Noguchi; E Richards; A Jungbluth; H Wada; M Moore; B Williamson; S Basu; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 2.  Overproduction of nitric oxide in pathophysiology of blood vessels.

Authors:  J C Stoclet; B Muller; R Andriantsitohaina; A Kleschyov
Journal:  Biochemistry (Mosc)       Date:  1998-07       Impact factor: 2.487

3.  Pyrrolidine dithiocarbamate inhibits immunostimulant-induced tetrahydrobiopterin synthesis in rat vascular smooth muscle.

Authors:  Y Hattori; N Nakanishi; K Kasai; S I Shimoda; S S Gross
Journal:  Eur J Pharmacol       Date:  1996-01-18       Impact factor: 4.432

4.  Adherent neutrophils activate endothelial myosin light chain kinase: role in transendothelial migration.

Authors:  J G Garcia; A D Verin; M Herenyiova; D English
Journal:  J Appl Physiol (1985)       Date:  1998-05

5.  Myosin light chain kinase in endothelium: molecular cloning and regulation.

Authors:  J G Garcia; V Lazar; L I Gilbert-McClain; P J Gallagher; A D Verin
Journal:  Am J Respir Cell Mol Biol       Date:  1997-05       Impact factor: 6.914

6.  Properties of filament-bound myosin light chain kinase.

Authors:  P Lin; K Luby-Phelps; J T Stull
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

7.  Alteration by lipopolysaccharide of the relationship between intracellular calcium levels and contraction in rat mesenteric artery.

Authors:  M C Martínez; B Muller; J C Stoclet; R Andriantsitohaina
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

8.  Effect of bacterial lipopolysaccharide on function of rat small femoral arteries.

Authors:  F Schneider; B Bucher; C Schott; A Andre; G Julou-Schaeffer; J C Stoclet
Journal:  Am J Physiol       Date:  1994-01

9.  Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis.

Authors:  F J Miller; D D Gutterman; C D Rios; D D Heistad; B L Davidson
Journal:  Circ Res       Date:  1998-06-29       Impact factor: 17.367

10.  Multiple gene products are produced from a novel protein kinase transcription region.

Authors:  D M Watterson; M Collinge; T J Lukas; L J Van Eldik; K G Birukov; O V Stepanova; V P Shirinsky
Journal:  FEBS Lett       Date:  1995-10-16       Impact factor: 4.124

View more
  16 in total

Review 1.  Targeting protein kinases in central nervous system disorders.

Authors:  Laura K Chico; Linda J Van Eldik; D Martin Watterson
Journal:  Nat Rev Drug Discov       Date:  2009-11       Impact factor: 84.694

2.  Nonmuscle myosin light-chain kinase deficiency attenuates atherosclerosis in apolipoprotein E-deficient mice via reduced endothelial barrier dysfunction and monocyte migration.

Authors:  Chongxiu Sun; Mack H Wu; Sarah Y Yuan
Journal:  Circulation       Date:  2011-06-13       Impact factor: 29.690

3.  Nonmuscle myosin light-chain kinase mediates microglial migration induced by HIV Tat: involvement of β1 integrins.

Authors:  Honghong Yao; Ming Duan; Lu Yang; Shilpa Buch
Journal:  FASEB J       Date:  2013-01-04       Impact factor: 5.191

4.  Myosin light chain kinase knockout improves gut barrier function and confers a survival advantage in polymicrobial sepsis.

Authors:  C Adam Lorentz; Zhe Liang; Mei Meng; Ching-Wen Chen; Benyam P Yoseph; Elise R Breed; Rohit Mittal; Nathan J Klingensmith; Alton B Farris; Eileen M Burd; Michael Koval; Mandy L Ford; Craig M Coopersmith
Journal:  Mol Med       Date:  2017-06-07       Impact factor: 6.354

5.  Non-muscle Mlck is required for β-catenin- and FoxO1-dependent downregulation of Cldn5 in IL-1β-mediated barrier dysfunction in brain endothelial cells.

Authors:  Richard S Beard; Ricci J Haines; Kevin Y Wu; Jason J Reynolds; Stephanie M Davis; John E Elliott; Nikolay L Malinin; Victor Chatterjee; Byeong J Cha; Mack H Wu; Sarah Y Yuan
Journal:  J Cell Sci       Date:  2014-02-12       Impact factor: 5.285

Review 6.  Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock.

Authors:  Ineke Vanlaere; Claude Libert
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

7.  Membrane Permeant Inhibitor of Myosin Light Chain Kinase Worsens Survival in Murine Polymicrobial Sepsis.

Authors:  Yini Sun; Takehiko Oami; Zhe Liang; Ashley A Miniet; Eileen M Burd; Mandy L Ford; Craig M Coopersmith
Journal:  Shock       Date:  2021-10-01       Impact factor: 3.533

8.  Activation of Endothelial Pro-resolving Anti-Inflammatory Pathways by Circulating Microvesicles from Non-muscular Myosin Light Chain Kinase-Deficient Mice.

Authors:  Abderahim Gaceb; Luisa Vergori; M C Martinez; Ramaroson Andriantsitohaina
Journal:  Front Pharmacol       Date:  2016-09-21       Impact factor: 5.810

9.  TLR4 activation of TRPC6-dependent calcium signaling mediates endotoxin-induced lung vascular permeability and inflammation.

Authors:  Mohammad Tauseef; Nebojsa Knezevic; Koteswara R Chava; Monica Smith; Sukriti Sukriti; Nicholas Gianaris; Alexander G Obukhov; Stephen M Vogel; Dean E Schraufnagel; Alexander Dietrich; Lutz Birnbaumer; Asrar B Malik; Dolly Mehta
Journal:  J Exp Med       Date:  2012-10-08       Impact factor: 14.307

10.  Critical role of non-muscle myosin light chain kinase in thrombin-induced endothelial cell inflammation and lung PMN infiltration.

Authors:  Fabeha Fazal; Kaiser M Bijli; Matthew Murrill; Antony Leonard; Mohammad Minhajuddin; Khandaker N Anwar; Jacob N Finkelstein; D Martin Watterson; Arshad Rahman
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.